, Zostavax, has been approved by the FDA for usage in the prevention of shingles in those 60 years of age and older. In clinical trials, it reduced the risk of developing shingles by about 50%. Persons with a history of anaphylaxis (a type of a very bad allergic reaction) to neomycin should not receive this vaccine. In addition, avoiding undue stress and fatigue may theoretically help prevent an outbreak.
Please be aware that this information is provided to supplement the care
provided by your physician. It is neither intended nor implied to be a
substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER
IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the
advice of your physician or other qualified health provider prior to
starting any new treatment or with any questions you may have regarding a